Bifidobacterium longum subsp. infantis BI221 (LMG P-29639)

Discover characteristics, functionalities and scientific support of Bifidobacterium longum subsp. infantis BI221 (LMG P-29639).

Antioxidant Immune stimulation

Thearapeutical Area(s): Immune system

Age/Gender: Adults

Bifidobacterium longum subsp. infantis BI221 (LMG P-29639), developed by SynBalance.
Gastrointestinal Health • Immune prevention

Scientific reference(s)

Search on Pubmed

Bifidobacterium longum subsp. infantis BI221 (LMG P-29639) is available at

SynBalance SRL

Probiotics, LBPs, prebiotics & postbiotics + Production & Manufacturing

Probiotic blends with Bifidobacterium longum subsp. infantis BI221 (LMG P-29639)

Wellderly

MicrobiomePost

MicrobiomeHUB

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomePost’s Privacy Policy

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.